Gilead Sciences, Inc. (GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	90,399	100,942	107,677	91,081	73,031	82,209
Market Cap Growth	-11.81%	-6.25%	18.22%	24.72%	-11.16%	1.60%
Enterprise Value	110,875	118,665	126,522	111,256	97,025	82,450
PE Ratio	207.31	17.82	23.45	14.63	593.74	15.26
PS Ratio	3.29	3.72	3.95	3.34	2.96	3.66
PB Ratio	5.15	4.42	5.07	4.32	4.01	3.65
P/FCF Ratio	11.44	13.60	12.90	8.43	9.71	9.88
P/OCF Ratio	10.66	12.61	11.87	8.00	8.94	8.99
EV/Sales Ratio	4.04	4.38	4.64	4.07	3.93	3.67
EV/EBITDA Ratio	23.04	11.25	14.25	9.80	23.28	10.88
EV/EBIT Ratio	53.59	15.10	18.67	11.96	36.11	13.35
EV/FCF Ratio	14.03	15.99	15.16	10.30	12.91	9.91
Debt / Equity Ratio	1.44	1.09	1.19	1.27	1.73	1.09
Debt / EBITDA Ratio	5.24	2.37	2.84	2.35	7.54	3.24
Debt / FCF Ratio	3.19	3.37	3.02	2.47	4.18	2.96
Quick Ratio	0.72	1.06	0.99	0.95	1.08	2.86
Current Ratio	1.08	1.43	1.29	1.27	1.40	3.10
Asset Turnover	0.45	0.44	0.43	0.40	0.40	0.36
Interest Coverage	2.14	8.32	7.25	9.29	2.73	6.21
Return on Equity (ROE)	2.30%	26.00%	22.30%	30.70%	0.60%	24.60%
Return on Assets (ROA)	0.80%	9.10%	7.30%	9.20%	0.20%	8.70%
Return on Capital (ROIC)	1.62%	13.03%	12.40%	15.57%	0.59%	9.46%
Earnings Yield	0.54%	5.61%	4.26%	6.83%	0.17%	6.55%
FCF Yield	8.74%	7.35%	7.75%	11.86%	10.29%	10.12%
Dividend Yield	4.25%	3.70%	3.40%	3.90%	4.70%	3.90%
Payout Ratio	880.00%	66.10%	79.80%	57.30%	2720.00%	59.40%
Buyback Yield / Dilution	1.11%	0.32%	0.08%	0.08%	1.10%	2.37%
Total Shareholder Return	5.36%	4.02%	3.48%	3.98%	5.80%	6.27%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).